Maculopapular rash with multiple drug hypersensitivity to cotrimoxazole, amikacin, piperacillin/tazobactam, and meropenem in a patient with hairy cell leukemia.
{"title":"Maculopapular rash with multiple drug hypersensitivity to cotrimoxazole, amikacin, piperacillin/tazobactam, and meropenem in a patient with hairy cell leukemia.","authors":"Katie Townsend, Claire Leck, Thippeswamy Billahalli, Elizabeth Barachina, Timothy J Watts","doi":"10.5414/ALX02508E","DOIUrl":null,"url":null,"abstract":"<p><p>We describe a rare case of a 54-year-old female with hairy cell leukemia, who following treatment for neutropenic sepsis, developed an extensive severe maculopapular exanthema with perifollicular hemorrhage. Cladribine, cotrimoxazole, allopurinol, domperidone, amikacin, piperacillin/tazobactam, and meropenem had all been given in the 9 days prior to eruption onset. Three months later, drug patch testing/delayed intradermal testing was positive to cotrimoxazole, trimethoprim, amikacin, piperacillin/tazobactam, and meropenem, with additional evidence of penicillin cross-reactivity. Drug challenge tests were negative to allopurinol and domperidone. She was diagnosed with multiple drug hypersensitivity to cotrimoxazole, amikacin, piperacillin/tazobactam, and meropenem. Multiple drug hypersensitivity is a novel syndrome mainly seen with severe delayed type IV drug eruptions, involving long-lasting strong T-cell reactivity to two or more structurally unrelated drugs.</p>","PeriodicalId":101298,"journal":{"name":"Allergologie select","volume":"8 ","pages":"265-269"},"PeriodicalIF":0.0000,"publicationDate":"2024-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11270333/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Allergologie select","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5414/ALX02508E","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
We describe a rare case of a 54-year-old female with hairy cell leukemia, who following treatment for neutropenic sepsis, developed an extensive severe maculopapular exanthema with perifollicular hemorrhage. Cladribine, cotrimoxazole, allopurinol, domperidone, amikacin, piperacillin/tazobactam, and meropenem had all been given in the 9 days prior to eruption onset. Three months later, drug patch testing/delayed intradermal testing was positive to cotrimoxazole, trimethoprim, amikacin, piperacillin/tazobactam, and meropenem, with additional evidence of penicillin cross-reactivity. Drug challenge tests were negative to allopurinol and domperidone. She was diagnosed with multiple drug hypersensitivity to cotrimoxazole, amikacin, piperacillin/tazobactam, and meropenem. Multiple drug hypersensitivity is a novel syndrome mainly seen with severe delayed type IV drug eruptions, involving long-lasting strong T-cell reactivity to two or more structurally unrelated drugs.
我们描述了一例罕见的病例:一名 54 岁的女性毛细胞白血病患者在接受中性败血症治疗后,出现了大面积严重的斑丘疹性外伤,并伴有毛囊周围出血。发病前 9 天内曾服用过克拉利宾、复方新诺明、别嘌呤醇、多潘立酮、阿米卡星、哌拉西林/他唑巴坦和美罗培南。三个月后,药物贴片测试/延迟皮内测试结果显示,复方新诺明、三甲氧苄啶、阿米卡星、哌拉西林/他唑巴坦和美罗培南呈阳性反应,并有青霉素交叉反应的其他证据。对别嘌呤醇和多潘立酮的药物挑战试验呈阴性。她被诊断为对复方新诺明、阿米卡星、哌拉西林/他唑巴坦和美罗培南等多种药物过敏。多重药物过敏症是一种新型综合征,主要表现为严重的迟发性 IV 型药物爆发,涉及对两种或两种以上结构不相关药物的长期强烈 T 细胞反应。